Icon Genetics GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Icon Genetics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013244
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Icon Genetics GmbH (Icon Genetics) a subsidiary of Bayer AG is a biotechnology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and plant-based production. It also develops and commercializes proprietary transgene operating systems suites of technologies for nuclear transformation of plants, plastid transformation and pro-viral transfection of plants. Icon Genetics discovers and develops biopharmaceuticals and protein products using green plants as production hosts. The company provides its production platforms and product prototypes for pharmaceutical, animal health and chemical biotech markets. Icon Genetics is headquartered in Halle, Germany.

Icon Genetics GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Merger 11
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Acquisition 12
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH – Key Competitors 14
Icon Genetics GmbH – Key Employees 15
Icon Genetics GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Icon Genetics GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH, Key Competitors 14
Icon Genetics GmbH, Key Employees 15

★海外企業調査レポート[Icon Genetics GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Northern Trust Corporation:企業のM&A・事業提携・投資動向
    Northern Trust Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Northern Trust Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian …
  • Polarcus Ltd (PLCS):石油・ガス:M&Aディール及び事業提携情報
    Summary Polarcus Ltd (Polarcus) is a marine geophysical company that provides towed streamer data acquisition and imaging services. The company provides marine acquisition services such as vessel specifications, increasing efficiency, managing emissions to air, managing emissions to sea, polar code …
  • Aker Solutions ASA:企業のM&A・事業提携・投資動向
    Aker Solutions ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aker Solutions ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Koei Tecmo Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Koei Tecmo Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Koei Tecmo Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Blood Cell Storage Inc:医療機器:M&Aディール及び事業提携情報
    Summary Blood Cell Storage Inc (BCSI) is a medical device company that discovers and develops bio-medical technology products. The company’s products comprise IVF safe sens, platelets ph safe, and nucleic acid extraction systems, among others. Its IVF safe sens comprise trackstation and in-vessel mo …
  • Asure Software, Inc. (ASUR):企業の財務・戦略的SWOT分析
    Asure Software, Inc. (ASUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tsumura & Co.:企業の戦略・SWOT・財務情報
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bank of Japan (8301):企業の財務・戦略的SWOT分析
    Bank of Japan (8301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • EMD Serono Inc-製薬・医療分野:企業M&A・提携分析
    Summary EMD Serono Inc (EMD), formerly Serono Inc, a subsidiary of Merck KGaA is a healthcare products provider that offers oncology products. The company offers neurology and immunology; metabolic endocrinology, fertility and oncology products. It offers neurology and immunology products to find ne …
  • Bharat Road Network Limited (BRNL):企業の財務・戦略的SWOT分析
    Bharat Road Network Limited (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PPG Industries Inc (PPG):企業の財務・戦略的SWOT分析
    PPG Industries Inc (PPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • HanAll Biopharma Co Ltd (009420):企業の財務・戦略的SWOT分析
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, musculoskeletal and urinary system. The company’s pipeline products include HL036, a drug being developed for trea …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gannett Co., Inc.:戦略・SWOT・企業財務分析
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ono Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析
    Ono Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ono Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • AVX Corp (AVX):企業の財務・戦略的SWOT分析
    AVX Corp (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • First Quantum Minerals Ltd:企業のM&A・事業提携・投資動向
    First Quantum Minerals Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Quantum Minerals Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Reynard Corp:企業の戦略・SWOT・財務分析
    Reynard Corp - Strategy, SWOT and Corporate Finance Report Summary Reynard Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Empyrean Energy PLC (EME):企業の財務・戦略的SWOT分析
    Summary Empyrean Energy PLC (Empyrean Energy) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company's projects include China Block 29/11 project, Duyung PSC project, and Sacramento Basin Projects. Its Duyung PSC project covers a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆